EW FY 2025 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6.1B+11.5% YoY

Gross Profit

$4.7B78.1% margin

Operating Income

$1.6B27.0% margin

Net Income

$1.1B17.7% margin

EPS (Diluted)

$1.83

Cash Flow

Operating Cash Flow

$1.6B

Free Cash Flow

$1.3B

Stock-Based Comp.

$158M

Balance Sheet

Total Assets

$13.7B

Total Liabilities

$3.4B

Stockholders' Equity

$10.3B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.1B	$5.4B	+11.5%
Gross Profit	$4.7B	$4.3B	+9.7%
Operating Income	$1.6B	$1.4B	+18.7%
Net Income	$1.1B	$4.2B	-74.3%